ANAPTYSBIO, INC. (ANAB) Operating margin 2016–2025
ANAPTYSBIO, INC. (ANAB) operating margin by fiscal year — reported operating income divided by reported revenue.
20.4%FY2025 · since FY2016: -18.1% → 20.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 20.4% | +146.3 pp |
| FY2024 | -125.9% | +832.3 pp |
| FY2023 | -958.3% | +161.1 pp |
| FY2022 | -1119.4% | -1029.5 pp |
| FY2021 | -89.9% | -58.1 pp |
| FY2020 | -31.8% | +1311.1 pp |
| FY2019 | -1342.9% | -8.5 pp |
| FY2018 | -1334.4% | -1046.6 pp |
| FY2017 | -287.8% | -269.7 pp |
| FY2016 | -18.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice